Holen Sie sich die Stockscreener-App
1.52
2.70%
0.04
Handel nachbörslich:
1.53
0.01
+0.66%
Schlusskurs vom Vortag:
$1.48
Offen:
$1.48
24-Stunden-Volumen:
253.10K
Relative Volume:
0.49
Marktkapitalisierung:
$40.41M
Einnahmen:
$155.00K
Nettoeinkommen (Verlust:
$-30.01M
KGV:
-0.9102
EPS:
-1.67
Netto-Cashflow:
$-11.98M
1W Leistung:
+1.33%
1M Leistung:
-20.00%
6M Leistung:
-79.18%
1J Leistung:
-68.33%
1-Tages-Spanne:
$1.46
$1.53
1-Wochen-Bereich:
$1.4499
$1.62
52-Wochen-Spanne:
$1.38
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Firmenname
Inmune Bio Inc
Sektor
Branche
Telefon
(858) 964-3720
Adresse
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Vergleichen Sie INMB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.52 | 39.35M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-01 | Herabstufung | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-10-21 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-09-27 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-06-01 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-05-24 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | Bestätigt | Maxim Group | Buy |
| 2021-04-21 | Eingeleitet | B. Riley Securities | Buy |
| 2021-01-22 | Bestätigt | Maxim Group | Buy |
| 2020-09-01 | Eingeleitet | BTIG Research | Buy |
| 2020-07-15 | Bestätigt | H.C. Wainwright | Buy |
Alle ansehen
Inmune Bio Inc Aktie (INMB) Neueste Nachrichten
INmune Bio Inc Stock Analysis and ForecastStock Buy Signals & Minimal Capital Appreciation - earlytimes.in
Is INmune Bio Inc. stock positioned for long term growth2025 Technical Overview & Technical Buy Zone Confirmation - newser.com
Analyzing recovery setups for INmune Bio Inc. investorsMarket Sentiment Report & Verified Swing Trading Watchlist - newser.com
Is INmune Bio Inc. a candidate for recovery playWeekly Gains Report & Consistent Profit Alerts - newser.com
Why INmune Bio Inc. stock is a value investor pickRisk Management & Daily Entry Point Alerts - newser.com
Heatmap analysis for INmune Bio Inc. and competitorsWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Short interest data insights for INmune Bio Inc.Market Trend Review & Verified Technical Signals - newser.com
How INmune Bio Inc. stock benefits from global expansionMarket Sentiment Summary & Reliable Price Action Trade Plans - newser.com
Candlestick signals on INmune Bio Inc. stock today2025 Momentum Check & Expert Curated Trade Ideas - newser.com
INmune Bio (INMB) Stock Analysis Report | Financials & Insights - Benzinga
INmune Bio Inc. (INMB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Does INmune Bio Inc. stock trade at a discount to peers2025 Market Outlook & Growth Focused Investment Plans - newser.com
[Form 4] Inmune Bio, Inc. Insider Trading Activity - Stock Titan
INmune Bio Approves Option Repricing Proposal - TipRanks
[8-K] Inmune Bio, Inc. Reports Material Event | INMB SEC FilingForm 8-K - Stock Titan
INmune Bio, Inc. Announces Presentations at 18th Clinical Trials on Alzheimer’s Disease Conference - Quiver Quantitative
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference - Bluefield Daily Telegraph
How INmune Bio Inc. stock reacts to Fed rate cutsJuly 2025 Technicals & Expert Curated Trade Setup Alerts - newser.com
INmune Bio Inc.Common stock (NQ: INMB - FinancialContent
Statistical indicators supporting INmune Bio Inc.’s strengthShare Buyback & AI Powered Market Trend Analysis - newser.com
Will INmune Bio Inc. stock outperform tech sector in 2025Weekly Profit Report & Proven Capital Preservation Methods - newser.com
Sentiment analysis tools applied to INmune Bio Inc.Dollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
INmune Bio Inc (0Y2.BE) stock price, news, quote and history - Yahoo Finance Singapore
Is it time to cut losses on INmune Bio Inc.2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com
Finanzdaten der Inmune Bio Inc-Aktie (INMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):